Early-life microbiome shapes allergic, metabolic, and respiratory disease risk

This narrative review explores the role of the human gut and lung microbiome during early life in the development of allergic diseases, metabolic disorders, and respiratory illnesses. The authors synthesize existing evidence suggesting that microbial composition and diversity in infancy may influence long-term health outcomes. They propose a theoretical framework linking early-life microbiome perturbations to increased risk of these conditions, emphasizing the potential for microbiome-targeted interventions in disease prevention.

Key findings are qualitative, as the review does not report pooled effect sizes or specific study results. The authors highlight associations between early-life microbial exposure and immune system maturation, metabolic programming, and respiratory health. However, they note that the evidence is largely observational and that causal pathways remain to be established.

Limitations acknowledged include the heterogeneity of study designs, lack of standardized microbiome assessment methods, and confounding factors such as diet, antibiotic use, and mode of delivery. The review does not provide specific clinical recommendations but offers a theoretical reference for future research and early-life health protection strategies.

Practice relevance is theoretical at this stage. Clinicians should interpret the findings as hypothesis-generating rather than actionable, and await further prospective studies and interventional trials before considering microbiome-based preventive measures.